These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 20303754)
1. Praziquantel analogs with activity against juvenile Schistosoma mansoni. Dong Y; Chollet J; Vargas M; Mansour NR; Bickle Q; Alnouti Y; Huang J; Keiser J; Vennerstrom JL Bioorg Med Chem Lett; 2010 Apr; 20(8):2481-4. PubMed ID: 20303754 [TBL] [Abstract][Full Text] [Related]
2. Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro. Keiser J; Manneck T; Vargas M J Antimicrob Chemother; 2011 Aug; 66(8):1791-7. PubMed ID: 21602552 [TBL] [Abstract][Full Text] [Related]
3. Triclabendazole and its two main metabolites lack activity against Schistosoma mansoni in the mouse model. Keiser J; El Ela NA; El Komy E; El Lakkany N; Diab T; Chollet J; Utzinger J; Barakat R Am J Trop Med Hyg; 2006 Aug; 75(2):287-91. PubMed ID: 16896134 [TBL] [Abstract][Full Text] [Related]
4. Susceptibility to praziquantel of male and female cercariae of praziquantel-resistant and susceptible isolates of Schistosoma mansoni. Liang YS; Wang W; Dai JR; Li HJ; Tao YH; Zhang JF; Li W; Zhu YC; Coles GC; Doenhoff MJ J Helminthol; 2010 Jun; 84(2):202-7. PubMed ID: 19765323 [TBL] [Abstract][Full Text] [Related]
5. Drug-metabolizing enzymes and praziquantel bioavailability in mice harboring Schistosoma mansoni isolates of different drug susceptibilities. Botros SS; El-Din SH; El-Lakkany NM; Sabra AN; Ebeid FA J Parasitol; 2006 Dec; 92(6):1344-9. PubMed ID: 17304818 [TBL] [Abstract][Full Text] [Related]
6. Biological characteristics of praziquantel-resistant and -susceptible isolates of Schistosoma mansoni. Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ Ann Trop Med Parasitol; 2001 Oct; 95(7):715-23. PubMed ID: 11784425 [TBL] [Abstract][Full Text] [Related]
7. In vitro metabolic profile and in vivo antischistosomal activity studies of (η(6)-praziquantel)Cr(CO)3 derivatives. Patra M; Ingram K; Leonidova A; Pierroz V; Ferrari S; Robertson MN; Todd MH; Keiser J; Gasser G J Med Chem; 2013 Nov; 56(22):9192-8. PubMed ID: 24219617 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni. Mattos AC; Pereira GC; Jannotti-Passos LK; Kusel JR; Coelho PM Acta Trop; 2007 May; 102(2):84-91. PubMed ID: 17498638 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antischistosomal activity of a new 2-nicotinoyl dipeptide analogue of praziquantel. Abo-Ghalia MH; Soliman AE Arzneimittelforschung; 1996 Feb; 46(2):207-9. PubMed ID: 8720316 [TBL] [Abstract][Full Text] [Related]
10. Use of fluorescent probes as a useful tool to identify resistant Schistosoma mansoni isolates to praziquantel. Couto FF; Coelho PM; Araújo N; Kusel JR; Katz N; Mattos AC Parasitology; 2010 Oct; 137(12):1791-7. PubMed ID: 20561394 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of oral therapy on Mansonial Schistosomiasis using single dose of Balanites aegyptiaca fruits and praziquantel. Koko WS; Abdalla HS; Galal M; Khalid HS Fitoterapia; 2005 Jan; 76(1):30-4. PubMed ID: 15664459 [TBL] [Abstract][Full Text] [Related]
13. Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum. Duan WW; Qiu SJ; Zhao Y; Sun H; Qiao C; Xia CM Bioorg Med Chem Lett; 2012 Feb; 22(4):1587-90. PubMed ID: 22264473 [TBL] [Abstract][Full Text] [Related]
14. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo. Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638 [TBL] [Abstract][Full Text] [Related]
15. Development of chiral praziquantel analogues as potential drug candidates with activity to juvenile Schistosoma japonicum. Zheng Y; Dong L; Hu C; Zhao B; Yang C; Xia C; Sun D Bioorg Med Chem Lett; 2014 Sep; 24(17):4223-6. PubMed ID: 25127102 [TBL] [Abstract][Full Text] [Related]
16. Praziquantel and the benzodiazepine Ro 11-3128 do not compete for the same binding sites in schistosomes. Pica-Mattoccia L; Ruppel A; Xia CM; Cioli D Parasitology; 2008 Jan; 135(Pt 1):47-54. PubMed ID: 17767796 [TBL] [Abstract][Full Text] [Related]
17. Lack of evidence for an antischistosomal activity of myrrh in experimental animals. Botros S; William S; Ebeid F; Cioli D; Katz N; Day TA; Bennett JL Am J Trop Med Hyg; 2004 Aug; 71(2):206-10. PubMed ID: 15306712 [TBL] [Abstract][Full Text] [Related]
19. Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Pica-Mattoccia L; Cioli D Int J Parasitol; 2004 Mar; 34(4):527-33. PubMed ID: 15013742 [TBL] [Abstract][Full Text] [Related]
20. Responses of the surface membrane and excretory system of Schistosoma mansoni to damage and to treatment with praziquantel and other biomolecules. Oliveira FA; Kusel JR; Ribeiro F; Coelho PM Parasitology; 2006 Mar; 132(Pt 3):321-30. PubMed ID: 16318676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]